That's replaced in this new bill by clause 4 of the bill, which replaces that section 23(1) with this subsection (1), which says, "Notwithstanding sections 20 to 22, the Minister may, by notice in the Gazette, in accordance with this section, give provisional consent to the sale or supply or use of a new medicine if the Minister is of the opinion that it is desirable that the medicine be sold, supplied, or used." So other than making it gender-neutral language, the only change here is to remove the reference to "a limited number of patients". That is the change, in effect, as I understand it, and that change is not just for the benefit of the listed consents that are being retrospectively validated; it also applies to other applications for provisional consents in the future, should they be made. Of course, that could all become overtaken eventually by the replacement in the therapeutic goods bill, but we don't need that in order to have a functioning mechanism in respect of provisional approvals for new vaccines or other medicines. That was a question to the Minister as to whether my understanding is correct.